Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study)
Top Cited Papers
- 18 June 2008
- journal article
- clinical trial
- Published by Elsevier in The Lancet Oncology
- Vol. 9 (7), 621-628
- https://doi.org/10.1016/s1470-2045(08)70155-4
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Influence of chronic obstructive pulmonary disease on postoperative lung function and complications in patients undergoing operations for primary non–small cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2007
- Stereotactic single‐dose radiotherapy (radiosurgery) of early stage nonsmall‐cell lung cancer (NSCLC)Cancer, 2007
- Characterization of the RF ablation-induced ‘oven effect’: The importance of background tissue thermal conductivity on tissue heatingInternational Journal of Hyperthermia, 2006
- Management of Hepatocellular Carcinoma *Hepatology, 2005
- Proper Treatment Selection May Improve Survival in Patients With Clinical Early-Stage Nonsmall Cell Lung CancerThe Annals of Thoracic Surgery, 2005
- Surgical Treatment for Lung Cancer with COPD Based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD)The Thoracic and Cardiovascular Surgeon, 2005
- Radiofrequency ablation for the treatment of non–small cell lung cancer in marginal surgical candidatesThe Journal of Thoracic and Cardiovascular Surgery, 2005
- Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤4 cmGastroenterology, 2004
- Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic reviewThorax, 2001
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000